Welcome to P3P
Personal Patient Profile - Prostate
Helping you make decisions about prostate cancer
Learn more about P3P
P3P is for
Patients
By building a personalized profile that provides information about managing a diagnosis of prostate cancer.
Clinicians
By providing cancer care options that allow patients to share their values, preferences, and choices with the clinician.
Demos for Clinicians
Try P3P as your patient would see it
(15 minutes)
View exemplar patient education and clinician summary only
(5 minutes)
In this exemplar education, the patient has already completed the P3P symptom and preference tool, and the demonstration is entered at the point where the patient can view tailored educational materials to help them better understand their treatment decision.
View exemplar clinician summary
View exemplar clinician summary
About P3P
P3P is a web-based program to help men prepare for making a decision, with their doctors, about how to manage a diagnosis of early stage prostate cancer. A recent national study* showed that using P3P reduced the amount of conflict experienced by men while making a decision.
This newest version of P3P (2021) has been developed in collaboration between professional stakeholders and the Clinical Informatics Research Group at the University of Washington in Seattle. The content of P3P was last updated in September, 2021 with the input of clinical professionals at:
- Emory University
- University of Kansas
- University of Michigan
- University of Southern California
- University of Washington
- University of Washington
- Donna Berry, Justin McReynolds, Ivan Cvitkovic, William Lober
To use P3P in your clinic, or if you have questions about P3P, contact p3phelp@uw.edu
Berry DL, Hong F, Blonquist TM, Halpenny B, Filson CP, Master VA, Sanda MG, Chang P, Chien GW, Jones RA, Krupski TL, Wolpin S, Wilson L, Hayes JH, Trinh QD, Sokoloff M, Somayaji P: Decision Support with the Personal Patient Profile-Prostate: A Multi-Center Randomized Trial. Journal of Urology, 2017; PMID: 28754540
National Institutes of Health Funding: R21 CA100025; 2003-2005; R01NR009692; 2006-2009; 2012-2017
